Scilex Holding Company (SCLX) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

Scilex Holding Company (SCLX) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry, with a market capitalization near $51.9M, listed on NASDAQ, employing roughly 115 people, carrying a beta of 1.79 to the broader market. Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid management products for the treatment of acute and chronic pain. Led by Henry H. Ji, public since 2021-03-05.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for SCLX as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →